Abstract
Rift Valley fever (RVF) is a severe infectious disease that can infect livestock and humans through mosquito bites, direct contact, and aerosol transmission. This study describes the development of a reverse transcription-loop-mediated isothermal amplification (RT-LAMP) assay combined with a vertical flow (VF) visualization strip for the rapid detection of the Rift Valley fever virus (RVFV). Targeting a conserved region of the S RNA segment, the assay achieved a detection limit of 1.94 copies/μl for synthetic RNA and 1.83 × 10³ copies/μl for viral RNA. The assay demonstrated 100-fold greater sensitivity than real-time RT-PCR, with no cross-reactivity against other febrile viruses. Results are visible within 5 minutes after a 60-minute amplification, making it a highly suitable tool for rapid, field-based diagnosis without specialized equipment.
Introduction
Rift Valley Fever (RVF) is a significant zoonotic threat, primarily affecting livestock and humans across Africa and the Arabian Peninsula. Outbreaks can spread rapidly due to multiple transmission routes, including mosquito vectors and direct contact with infected animal tissues. Current diagnostic "gold standards," such as virus neutralization tests and real-time RT-PCR, are often impractical in the remote, resource-limited settings where outbreaks typically occur. These methods require stable electricity, expensive thermal cyclers, or lengthy turnaround times (up to 7 days). There is a critical need for a point-of-care test that is sensitive, specific, and easy to interpret by eye.
Methods and Assay Design
The researchers developed a Reverse Transcription-Loop-Mediated Isothermal Amplification (RT-LAMP) assay. Unlike traditional PCR, LAMP operates at a constant temperature (63°C), allowing for amplification using simple heat blocks or water baths.
To ensure broad detection across various viral strains, the team designed six specific primers targeting a highly conserved 270 bp region of the RVFV S RNA segment.
For visual detection, loop primers were labeled with FITC and biotin. The amplified products are applied to a vertical flow visualization (VF) strip. If the target virus is present, the labeled DNA binds to gold-labeled streptavidin and is captured by antibodies on the strip, creating a visible red line—a format similar to a standard pregnancy test.
Results and Sensitivity
The assay was evaluated using synthetic RNA, inactivated RVFV-BJ01 strain, and mock clinical samples (inactivated virus mixed with human blood). A key finding was that the RT-LAMP-VF assay was 100-fold more sensitive than the standard real-time RT-PCR assay.
Key Performance Metrics:
- Detection Limit: 1.94 copies/µl for synthetic RNA; 1.83 × 10³ copies/µl for viral RNA.
- Speed: 60 minutes for amplification and 5 minutes for visual readout.
- Specificity: Zero cross-reactivity with other viruses causing similar symptoms, such as Japanese Encephalitis Virus, H3N2 influenza, and Ebola/Marburg proteins.
- Robustness: The assay remained effective even in the presence of whole blood components like heme, which often inhibit traditional PCR.
Discussion and Future Directions
The RVFV RT-LAMP-VF assay offers a significant advancement for field diagnostics. By combining high sensitivity with a closed-tube system that reduces aerosol contamination risks, it moves diagnostic capability from central laboratories directly to the clinic or "pen-side."
However, some limitations remain. While the primers target conserved regions, minor nucleotide mismatches in rare wild-type variants could potentially impact sensitivity. Future work should focus on validating the assay using "hot" clinical samples from active outbreaks in endemic regions and exploring the integration of this chemistry into digital platforms for automated epidemiological tracking.
Summary updated